CIBC Asset Management Inc Buys 1,162 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

CIBC Asset Management Inc grew its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 7.0% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 17,680 shares of the company’s stock after buying an additional 1,162 shares during the quarter. CIBC Asset Management Inc’s holdings in Henry Schein were worth $1,289,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Swedbank AB bought a new position in Henry Schein in the first quarter valued at about $215,998,000. ING Groep NV purchased a new position in shares of Henry Schein in the third quarter worth approximately $63,226,000. Thompson Siegel & Walmsley LLC purchased a new stake in Henry Schein during the second quarter valued at approximately $46,683,000. SG Americas Securities LLC raised its position in Henry Schein by 1,622.3% in the third quarter. SG Americas Securities LLC now owns 458,828 shares of the company’s stock worth $33,449,000 after acquiring an additional 432,187 shares during the period. Finally, Private Management Group Inc. purchased a new position in shares of Henry Schein during the 3rd quarter worth $24,176,000. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Henry Schein Stock Down 1.5 %

Shares of HSIC stock opened at $73.73 on Thursday. The company’s fifty day simple moving average is $70.68 and its two-hundred day simple moving average is $69.69. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.63. The stock has a market cap of $9.19 billion, a P/E ratio of 30.34, a PEG ratio of 1.97 and a beta of 0.87. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.17 by $0.05. The firm had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business’s revenue was up .4% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.32 earnings per share. Analysts predict that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms have recently commented on HSIC. StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Evercore ISI lifted their price objective on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research report on Tuesday, October 8th. Barrington Research reissued an “outperform” rating and issued a $82.00 target price on shares of Henry Schein in a report on Wednesday, November 6th. JPMorgan Chase & Co. lowered their price target on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a report on Monday, August 12th. Finally, Robert W. Baird reduced their price objective on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research note on Wednesday, August 7th. Six research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $78.89.

Insider Activity at Henry Schein

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the firm’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the sale, the senior vice president now directly owns 71,833 shares of the company’s stock, valued at $4,978,026.90. This trade represents a 22.65 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, COO Michael S. Ettinger sold 12,240 shares of the business’s stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the transaction, the chief operating officer now directly owns 87,706 shares in the company, valued at approximately $6,577,950. This represents a 12.25 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by insiders.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.